Table 1.
Subject characteristics (N = 1002)a.
Placebo (N = 335) | Q-500 (N = 334) | Q-1000 (N = 333) | All (N = 1002) | |
---|---|---|---|---|
(M = 123; F = 212) | (M = 138; F = 196) | (M = 134; F = 199) | (M = 395; F = 607) | |
Age (year) | ||||
Males | 43.8 ± 1.5 | 45.3 ± 1.2 | 45.5 ± 1.4 | 46.0 ± 0.5 |
Females | 47.4 ± 1.1 | 47.2 ± 1.1 | 45.2 ± 1.1 | (range 18–85) |
Weight (kg) | ||||
Males | 84.8 ± 1.4 | 85.7 ± 1.2 | 88.1 ± 1.5 | 77.2 ± 0.6 |
Females | 71.2 ± 1.1 | 71.6 ± 1.2 | 71.4 ± 1.3 | (42.7–157.5) |
Height (m) | ||||
Males | 1.77 ± 0.06 | 1.78 ± 0.04 | 1.77 ± 0.06 | 1.70 ± 0.03 |
Females | 1.64 ± 0.05 | 1.65 ± 0.05 | 1.64 ± 0.04 | (1.39–2.02) |
BMI (kg/m2) | ||||
Males | 27.0 ± 0.4 | 26.9 ± 0.4 | 28.1 ± 0.4 | 26.7 ± 0.2 |
Females | 26.4 ± 0.4 | 26.2 ± 0.4 | 26.4 ± 0.5 | (16.7–52.7) |
Education (year) | 15.5 ± 0.2 | 15.5 ± 0.2 | 15.8 ± 0.2 | 15.6 ± 0.1 |
Marital status | 34% single | 32% single | 33% single | 33% single |
53% married | 60% married | 55% married | 56% married | |
13% other | 8% other | 12% other | 11% other |
Data are presented as mean ± SEM.